Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371330 · ClinicalTrials.gov registry record
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study
A clinical trial, sponsored by Karolinska Institutet.
- Completed
- Registry status
- 76
- Enrollment target
NCT02371330: Completed study, sponsored by Karolinska Institutet.
NCT02371330 is a clinical trial that has completed, run by Karolinska Institutet. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02371330 has completed, sponsored by Karolinska Institutet.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
This is a prospective longitudinal study that evaluates Platelet Function Analyzer-100 (PFA-100) CT-ADPs (closure time-ADP) and incidence of bleeding using the Neonatal Bleeding Assessment Tool - Neo-BAT in preterm neonates \<32 weeks gestational age or with a birth weight \<1500 grams and with different degrees of thrombocytopenia. The investigators hypothesized that PFA-100 CT-ADP, a global in vitro test of primary hemostasis, will be a better predictor of clinical bleeding in neonates than platelet count alone. A bleeding risk assessment marker could help physicians more accurately determine the risk/benefit ratio of platelet transfusions, guiding platelet transfusion decisions in neonates with thrombocytopenia.
Primary Outcome
The NeoBAT is a simple, reliable and objective tool for the standardized assessment of bleeding in neonates, which was developed by an international team of experts based on the World Health Organization bleeding score for adults.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-09 |
What the finished NCT02371330 record still lists
NCT02371330 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02371330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02371330 about?
NCT02371330 is a clinical study titled "The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study". This is a prospective longitudinal study that evaluates Platelet Function Analyzer-100 (PFA-100) CT-ADPs (closure time-ADP) and incidence of bleeding using the Neonatal Bleeding Assessment Tool - Neo-BAT in preterm neonates \<32 weeks gestational age or with a birth weight \<1500 grams and with diff...
What is the current status of trial NCT02371330?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2015-04. Estimated completion is 2017-09.
Who is sponsoring clinical trial NCT02371330?
This trial is sponsored by Karolinska Institutet, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia